05.11.2020 12:53:41
|
Bio-Techne Q1 Profit Surges, Results Beat Estimates - Quick Facts
(RTTNews) - Life sciences company Bio-Techne Corp. (TECH) reported Thursday that its first-quarter net earnings surged to $33.40 million or $0.83 per share from $14.40 million or $0.37 per share in the prior-year quarter.
Excluding items, adjusted earnings were $1.43 per share, compared to $1.06 per share in the year-ago quarter.
Net sales for the quarter rose 11 percent to $204.20 million from last year's $183.24 million. Organic revenue growth was 10 percent.
On average, analysts polled by Thomson Reuters expected the company to report earnings of $1.09 per share on revenues of $185.03 million for the quarter. Analysts' estimates typically exclude special items.
Looking ahead, the company said it is anticipating a positive long-term outlook for sales growth resulting from expected future funding increases within life-science research in response to the current pandemic.
Separately, the company said its board of directors decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2020, payable November 27, 2020 to all common shareholders of record on November 16, 2020.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bio-Techne Corpmehr Nachrichten
10.02.25 |
Starker Wochentag in New York: S&P 500 verbucht Gewinne (finanzen.at) | |
10.02.25 |
Aufschläge in New York: Börsianer lassen S&P 500 am Montagmittag steigen (finanzen.at) | |
10.02.25 |
Handel in New York: S&P 500 bewegt sich zum Start im Plus (finanzen.at) | |
06.02.25 |
S&P 500-Titel Bio-Techne-Aktie: So viel Gewinn hätte ein Bio-Techne-Investment von vor 10 Jahren eingefahren (finanzen.at) | |
05.02.25 |
Verluste in New York: S&P 500 zum Handelsstart in Rot (finanzen.at) | |
04.02.25 |
Ausblick: Bio-Techne vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
30.01.25 |
S&P 500-Titel Bio-Techne-Aktie: So viel Gewinn hätte ein Investment in Bio-Techne von vor 5 Jahren abgeworfen (finanzen.at) | |
23.01.25 |
Gute Stimmung in New York: So steht der S&P 500 am Nachmittag (finanzen.at) |
Analysen zu Bio-Techne Corpmehr Analysen
Aktien in diesem Artikel
Bio-Techne Corp | 67,00 | -4,96% |
|